REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

68 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7.32M shares of 101M outstanding shares and own 7.22% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.8M shares), MILLENNIUM MANAGEMENT LLC (1.53M shares), DIADEMA PARTNERS LP (651K shares), TANG CAPITAL MANAGEMENT LLC (510K shares), GEODE CAPITAL MANAGEMENT, LLC (419K shares), Schonfeld Strategic Advisors LLC (258K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (231K shares), UBS Group AG (224K shares), MARSHALL WACE, LLP (216K shares), and Private Advisor Group, LLC (200K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.